Shanghai RAAS Blood Products Co Ltd Class A (002252) — Free Cash Flow Generation Index
Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Free Cash Flow Generation Index of 0.92x as of March 2025. Free cash flow of CN¥713.04 Million represents 1% of operating cash flow (CN¥775.56 Million). See Shanghai RAAS Blood Products Co Ltd Clas short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai RAAS Blood Products Co Ltd Class A Free Cash Flow Generation Index (2005–2023)
Historical FCF Generation Index trend for Shanghai RAAS Blood Products Co Ltd Class A across 18 annual periods. Explore Shanghai RAAS Blood Products Co Ltd Clas cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Shanghai RAAS Blood Products Co Ltd Class A (2005–2023)
Year-by-year Free Cash Flow Generation Index for Shanghai RAAS Blood Products Co Ltd Class A. For the full company profile including market capitalisation, see how much is Shanghai RAAS Blood Products Co Ltd Clas worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.80x | CN¥1.83 Billion | CN¥2.28 Billion | CN¥450.80 Million | ▼ -7.7% |
| 2022 | 0.87x | CN¥1.50 Billion | CN¥1.73 Billion | CN¥225.73 Million | ▲ +3.2% |
| 2021 | 0.84x | CN¥1.09 Billion | CN¥1.29 Billion | CN¥204.61 Million | ▲ +7.3% |
| 2020 | 0.78x | CN¥917.09 Million | CN¥1.17 Billion | CN¥251.76 Million | ▼ -4.6% |
| 2019 | 0.82x | CN¥717.86 Million | CN¥872.69 Million | CN¥154.84 Million | ▲ +104.6% |
| 2018 | 0.40x | CN¥105.56 Million | CN¥262.50 Million | CN¥156.94 Million | ▲ +0.9% |
| 2017 | 0.40x | CN¥107.11 Million | CN¥268.76 Million | CN¥157.84 Million | ▼ -48.2% |
| 2016 | 0.77x | CN¥490.74 Million | CN¥638.22 Million | CN¥147.49 Million | ▼ -5.0% |
| 2015 | 0.81x | CN¥617.03 Million | CN¥762.42 Million | CN¥145.39 Million | ▼ -5.9% |
| 2014 | 0.86x | CN¥400.90 Million | CN¥465.96 Million | CN¥65.06 Million | ▲ +99.3% |
| 2012 | 0.43x | CN¥113.77 Million | CN¥263.46 Million | CN¥149.70 Million | ▲ +6138.4% |
| 2011 | 0.01x | CN¥1.23 Million | CN¥178.03 Million | CN¥176.80 Million | ▼ -98.8% |
| 2010 | 0.55x | CN¥111.00 Million | CN¥200.21 Million | CN¥89.21 Million | ▲ +16.9% |
| 2009 | 0.47x | CN¥55.02 Million | CN¥116.01 Million | CN¥60.99 Million | ▼ -34.9% |
| 2008 | 0.73x | CN¥78.41 Million | CN¥107.64 Million | CN¥29.23 Million | ▼ -15.4% |
| 2007 | 0.86x | CN¥151.25 Million | CN¥175.71 Million | CN¥24.46 Million | ▲ +11.1% |
| 2006 | 0.77x | CN¥41.50 Million | CN¥53.58 Million | CN¥12.08 Million | ▲ +29.4% |
| 2005 | 0.60x | CN¥32.32 Million | CN¥54.02 Million | CN¥21.69 Million | — |